"Before turning to our first quarter results and outlook for the year, I want to start with our announcement of the acquisition of Campbell Lutyens, and the future establishment of Lazard CL, a new ...
Q1 2026 earnings call: 18% revenue growth, financing +48%, rate sensitivity, Q2 outlook, and buyback expansion—read key takeaways.
Creon (pancrelipase) is a prescription drug used to treat pancreatic insufficiency. Creon contains the active ingredient pancrelipase and comes as an oral delayed-release capsule. (This type of ...
Doxycycline is a prescription antibiotic used to treat certain infections and acne. Common side effects include diarrhea, nausea, vomiting, and increased sensitivity to sunlight. Serious side effects ...
MiraLAX is an over-the-counter laxative that works by pulling water into your colon to relieve constipation. Common mild side effects include bloating, gas, nausea, stomach cramping, and diarrhea or ...
Hosted on MSN
USA Today Co. reaffirms full-year outlook while expecting Q2 EBITDA growth at a “notably more moderate pace than Q1”
Earnings Call Insights: USA TODAY Co., Inc. (TDAY) Q1 2026 “I am pleased to report that we had an excellent start to the year.” (Chairman, CEO & President Michael Reed) Reed said “same-store declines ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results